Product-Specific Changes. If facility, equipment, process or system changes are required of ▇▇▇▇▇▇ as a result of requirements set forth by the FDA or any other Regulatory Authority, and such regulatory changes apply solely to the Production and supply of Product, then AMYLIN and ▇▇▇▇▇▇ will review such requirements and agree in writing to such regulatory changes, and AMYLIN shall bear [***]% of the reasonable costs thereof.
Appears in 2 contracts
Sources: Commercial Supply Agreement (Amylin Pharmaceuticals Inc), Commercial Supply Agreement (Amylin Pharmaceuticals Inc)